Related Experiment Videos
Caenorhabditis elegans as a model system for triplet repeat diseases
1Department of Pathology, Harvard Medical School, Charlestown, MA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|June 18, 2004
Summary
Caenorhabditis elegans offers a powerful model for studying neurological disorders like polyglutamine diseases. Its genetic tractability and cellular clarity enable detailed investigation into disease mechanisms and potential therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Model Organism Research
Background:
- Multicellular animals share conserved neuronal development and function pathways.
- Neurological disorders likely involve conserved genes and pathways implicated in neuronal degeneration.
- Studying complex human neurological diseases in simpler organisms is an effective research strategy.
Purpose of the Study:
- To describe tools and approaches for modeling triplet repeat diseases in Caenorhabditis elegans.
- To emphasize the use of C. elegans for modeling polyglutamine (polyQ) diseases.
- To explore methods for assessing candidate gene/pathway impacts on disease, cell death, and aging.
Main Methods:
- Utilizing Caenorhabditis elegans as a model organism for genetic studies.
- Leveraging C. elegans' ease of genetic manipulation, sequenced genome, and short life cycle.
- Employing precise identification and monitoring of specific neurons throughout the animal's lifespan.
Main Results:
- C. elegans provides an excellent genetic model for triplet repeat diseases, particularly polyglutamine diseases.
- The model allows for detailed study of neuronal development, survival, and degeneration.
- Potential avenues for assessing gene/pathway impacts on disease progression, cell death, and aging are addressed.
Conclusions:
- Caenorhabditis elegans is a valuable model for dissecting the molecular mechanisms of human neurological disorders.
- The described tools and approaches facilitate the creation and analysis of polyglutamine disease models.
- This model system aids in understanding the genetic basis of neurodegeneration and aging.